Why Valeant Is Getting Hit By Drug Pricing Concerns: Morgan Stanley By: Benzinga via Benzinga September 29, 2015 at 08:30 AM EDT Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares have been volatile over the last 5 trading days, down 27 percent since ... Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.